Thu, September 15, 2011
Wed, September 14, 2011
Tue, September 13, 2011
Mon, September 12, 2011
Sun, September 11, 2011
Sat, September 10, 2011
Fri, September 9, 2011
Thu, September 8, 2011
Wed, September 7, 2011
Tue, September 6, 2011
Mon, September 5, 2011
Sun, September 4, 2011
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011
Tue, August 30, 2011
[ Tue, Aug 30th 2011 ]: Market Wire
00 a.m. ET
Mon, August 29, 2011
Fri, August 26, 2011
Thu, August 25, 2011
Wed, August 24, 2011
Tue, August 23, 2011
Mon, August 22, 2011
Sat, August 20, 2011
Fri, August 19, 2011
Thu, August 18, 2011
Wed, August 17, 2011
[ Wed, Aug 17th 2011 ]: Market Wire
PPD???????BioDuro?????
Tue, August 16, 2011
Mon, August 15, 2011
Fri, August 12, 2011
Thu, August 11, 2011

Luminex Corporation to Present at Upcoming Investment Conferences In September

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. pcoming-investment-conferences-in-september.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Luminex Corporation to Present at Upcoming Investment Conferences In September -- AUSTIN, Texas, Aug. 30, 2011 /PRNewswire/ --

Luminex Corporation to Present at Upcoming Investment Conferences In September

[ ]

AUSTIN, Texas, Aug. 30, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: [ LMNX ]) announced today that management will present at two upcoming investment conferences, the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference, both scheduled to take place in New York City.

(Logo:  [ http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ])

Patrick J. Balthrop, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on September 13, 2011 at 1 p.m. Eastern time, and at the UBS Global Life Sciences Conference on September 19, 2011 at 10 a.m. Eastern time.

The presentations will be webcast live and may be accessed at Luminex Corporation's website at [ http://www.luminexcorp.com ].  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets.  The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.  Further information on Luminex Corporation or xMAP technology can be obtained at [ www.luminexcorp.com ].

Contacts:

Harriss T. Currie


Vice President, Finance and Chief Financial Officer


512-219-8020




Matthew Scalo


Sr. Director of Investor Relations


512-219-8020


[ mscalo@luminexcorp.com ]



SOURCE Luminex Corporation

[ Back to top ]

RELATED LINKS
[ http://www.luminexcorp.com ]